No abstract

No abstract

Introduction.A substantial amount of evidence supports exercise as crucial non-pharmacological management to slow down the progression of Parkinson's disease. despite that, people with Parkinson's disease are still known to be physically inactive. Hence, there is a need to investigate the exercise beliefs and participation benefits so that strategies can be developed to improve their exercise involvement. Methods. overall, 47 respondents from a non-governmental organization who met the inclusion criteria were recruited purposively to determine their beliefs concerning exercise. A cross-sectional survey was conducted with the use of a self-administered and validated questionnaire. Results. A significant proportion of the participants (80.9%) believed that exercise could help slow down the progression of Parkinson's disease; 17% were not sure and only 2.1% answered that exercise did not slow down the disease progression. The majority of the subjects (68%) were more likely to believe that exercise improved balance. Pertaining to the belief in physiotherapy for people with Parkinson's disease, 76.6% answered yes, 17% were not sure, and 6.4% said that they did not believe in physiotherapy for people with Parkinson's disease. Conclusions. The study revealed that most participants believed in exercise and were aware of its usefulness for their condition. However, they also reported that exercise and physiotherapy were not routinely recommended to them. So, still, awareness is needed of the exercise role and participation benefits.

Drug resistant strains are formed due to unsuitable uses of antibiotics and insufficient check of infections. In present years, due to the extensive antimicrobial properties, metallic nanoparticles and metallo-pharmaceutics are highly proposed. Therefore, the synthesis of bimetallic nanoparticles are exploring towards the evolution of more productive amalgamative antimicrobials composed of combined metals. In this study, the green synthesis of Cu-Ag bimetallic nano-alloys using aqueous extract from the leaves of Curcuma aromatica is carried out. Synthesized Cu-Ag nano-alloys were characterized by UV-visible spectroscopy, scanning electron microscope (FE-SEM), transmission electron microscope (TEM-EDAX), cyclic voltammogram (CV). The characterization studies reveals that the biosynthesis produced core-shell Cu-Ag nano-alloys with spherical shape and average diameter size of 15 nm. The synthesized Cu-Ag nanoalloys exhibited antibacterial activity against both Gram-positive and Gram-negative bacteria. The antidiabetic potential of Cu-Ag nanoalloys shows an effective inhibition against α-glucosidase. Anticancerous activity of Cu-Ag nanoalloys indicates its greater efficacy in destroying cancer cells. The biosynthesis of Cu-Ag nanoalloys can be employed in medical and industrial fields on a large scale with cost reductive method.